Publication | Closed Access

Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure

CardiomyopathyAntifibrotic TherapyHeart FailureChronic Heart FailureCardiovascular DiseaseStructural Heart DiseasePharmacologyCardiovascular PharmacologyMedicineCardiologyDiastolic Function